Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Feb 21, 2010; 16(7): 897-903
Published online Feb 21, 2010. doi: 10.3748/wjg.v16.i7.897
Figure 1
Figure 1 Expression of TLR4 in rat liver tissues. A: RT-PCR assay of TLR4 mRNA; B: Western blotting assay of TLR4 protein. 1: Control; 2: High dose betaine group; 3: Low dose betaine group; 4: Model; M: DNA marker.
Figure 2
Figure 2 Histopathological changes of rat liver after betaine intervention. A: In control group, liver structure was normal, without obvious inflammation and hepatic steatosis; B: In model group, the structure of hepatic cord was deranged, with various degrees of diffuse hepatic steatosis and intralobular inflammation; C: In low dose betaine group, the degree of hepatic steatosis and inflammation was greatly reduced compared with model group; D: High dose betaine group, showing more significant improvement of hepatic steatosis and inflammation than the low does betaine group. Original magnification × 400.